Motley Fool Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History
Motley Fool Wealth Management, LLC
- $1.87 Billion
- Q3 2024
A detailed history of Motley Fool Wealth Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Motley Fool Wealth Management, LLC holds 424,597 shares of BMRN stock, worth $28.3 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
424,597
Previous 445,703
4.74%
Holding current value
$28.3 Million
Previous $36.7 Million
18.67%
% of portfolio
1.59%
Previous 1.98%
Shares
20 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.26 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$926 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$699 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.4B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...